CY1637A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
CY1637A
CY1637A CY1637A CY163792A CY1637A CY 1637 A CY1637 A CY 1637A CY 1637 A CY1637 A CY 1637A CY 163792 A CY163792 A CY 163792A CY 1637 A CY1637 A CY 1637A
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
CY1637A
Other languages
English (en)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of CY1637A publication Critical patent/CY1637A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY1637A 1988-06-24 1992-11-06 Pharmaceutical compositions CY1637A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808497A FR2633181B1 (fr) 1988-06-24 1988-06-24 Composition pharmaceutique a base de ranitidine et son procede de preparation

Publications (1)

Publication Number Publication Date
CY1637A true CY1637A (en) 1992-11-06

Family

ID=9367671

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1637A CY1637A (en) 1988-06-24 1992-11-06 Pharmaceutical compositions

Country Status (32)

Country Link
US (1) US5102665A (pt)
JP (1) JPH0786086B2 (pt)
KR (1) KR940002662B1 (pt)
AT (1) AT396426B (pt)
AU (1) AU627194B2 (pt)
BE (1) BE1005691A4 (pt)
CA (1) CA1329130C (pt)
CH (1) CH679276A5 (pt)
CY (1) CY1637A (pt)
CZ (1) CZ280886B6 (pt)
DE (1) DE3920626C2 (pt)
DK (1) DK170223B1 (pt)
ES (1) ES2015717A6 (pt)
FR (1) FR2633181B1 (pt)
GB (1) GB2219940B (pt)
HK (1) HK33192A (pt)
HU (1) HU210067A9 (pt)
IE (1) IE60725B1 (pt)
IL (1) IL90731A (pt)
IT (1) IT1232149B (pt)
LU (1) LU87541A1 (pt)
MY (1) MY106412A (pt)
NL (1) NL8901596A (pt)
NZ (1) NZ229698A (pt)
PH (1) PH26018A (pt)
PT (1) PT90962B (pt)
SA (1) SA90100095B1 (pt)
SE (1) SE502285C2 (pt)
SG (1) SG21892G (pt)
SK (1) SK278823B6 (pt)
ZA (1) ZA894787B (pt)
ZW (1) ZW7889A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
WO2002089823A1 (fr) * 2001-04-27 2002-11-14 Kyoto Pharmaceutical Industries, Ltd. Methode de conservation pour un suppositoire
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
WO2005065319A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
CN105997922A (zh) * 2016-06-12 2016-10-12 佛山市腾瑞医药科技有限公司 一种盐酸雷尼替丁泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
ZW7889A1 (en) 1990-02-21
AU627194B2 (en) 1992-08-20
GB2219940A (en) 1989-12-28
DK314089A (da) 1989-12-25
ZA894787B (en) 1990-03-28
DE3920626C2 (de) 1994-12-22
SG21892G (en) 1992-04-16
PH26018A (en) 1992-01-29
NZ229698A (en) 1991-05-28
IE892047L (en) 1989-12-24
FR2633181A1 (fr) 1989-12-29
HK33192A (en) 1992-05-15
HU210067A9 (en) 1995-02-28
CZ403891A3 (en) 1993-08-11
AU3674489A (en) 1990-01-04
GB8914428D0 (en) 1989-08-09
SE8902288L (sv) 1989-12-25
ES2015717A6 (es) 1990-09-01
LU87541A1 (fr) 1990-02-28
JPH0245421A (ja) 1990-02-15
GB2219940B (en) 1992-01-02
DK314089D0 (da) 1989-06-23
DK170223B1 (da) 1995-07-03
SE502285C2 (sv) 1995-09-25
CZ280886B6 (cs) 1996-04-17
PT90962B (pt) 1994-12-30
NL8901596A (nl) 1990-01-16
MY106412A (en) 1995-05-30
CA1329130C (en) 1994-05-03
JPH0786086B2 (ja) 1995-09-20
US5102665A (en) 1992-04-07
IE60725B1 (en) 1994-08-10
FR2633181B1 (fr) 1992-01-10
KR940002662B1 (ko) 1994-03-28
BE1005691A4 (fr) 1993-12-21
IL90731A (en) 1994-04-12
SA90100095B1 (ar) 1999-06-30
IT8948116A0 (it) 1989-06-22
CH679276A5 (pt) 1992-01-31
SK403891A3 (en) 1998-03-04
DE3920626A1 (de) 1989-12-28
ATA154489A (de) 1993-01-15
SE8902288D0 (sv) 1989-06-22
IT1232149B (it) 1992-01-25
IL90731A0 (en) 1990-01-18
SK278823B6 (sk) 1998-03-04
PT90962A (pt) 1989-12-29
KR910000100A (ko) 1991-01-29
AT396426B (de) 1993-09-27

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
GB8904182D0 (en) Pharmaceutical compositions
HU896876D0 (en) Pharmaceutical compositions
GB8825892D0 (en) Pharmaceutical composition
EP0409499A3 (en) Pharmaceutical compositions
ZA893422B (en) Pharmaceutical composition
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
GB8814146D0 (en) Pharmaceutical compositions
GB8826289D0 (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
GB8830169D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
GB8808830D0 (en) Pharmaceutical compositions
IE882176L (en) Pharmaceutical compositions
GB8808117D0 (en) Pharmaceutical compositions
GB8804189D0 (en) Pharmaceutical compositions
GB8815444D0 (en) Pharmaceutical compositions
GB8830174D0 (en) Pharmaceutical compositions
GB8820265D0 (en) Pharmaceutical compositions
GB8801613D0 (en) Pharmaceutical compositions
GB8822507D0 (en) Pharmaceutical compositions
GB8809225D0 (en) Pharmaceutical compositions